C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 25mg |
7387 |
185989/13 |
ANDARAN PLUS |
|
28 |
Tablet, film coated |
Oral |
Khalil Fattal & Fils S.A.L. |
Pharmaline (Packing) under license from Sandoz, Austria |
Lebanon |
904,612 L.L |
23.08 |
A2 |
|
|
03/06/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 25mg |
7604 |
185813/13 |
GIZLAN-PLUS |
|
30 |
Tablet, film coated |
Oral |
Sadco |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
768,678 L.L |
23.08 |
A2 |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
03/06/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 25mg |
8514 |
185803/13 |
IBECARD PLUS 300/25 |
|
30 |
Tablet, film coated |
Oral |
IPS "Integrated Pharma Solutions SARL" |
Benta SAL |
Lebanon |
624,567 L.L |
23.08 |
A1 |
|
|
03/06/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 25mg |
12104 |
25118/1 |
IRTAN PLUS |
300mg |
30 |
Tablet |
Oral |
Pharmapro |
Mediphar Laboratories |
Lebanon |
601,530 L.L |
23.08 |
A1 |
|
|
03/06/20 |
|